[go: up one dir, main page]

NZ183136A - Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions - Google Patents

Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions

Info

Publication number
NZ183136A
NZ183136A NZ183136A NZ18313677A NZ183136A NZ 183136 A NZ183136 A NZ 183136A NZ 183136 A NZ183136 A NZ 183136A NZ 18313677 A NZ18313677 A NZ 18313677A NZ 183136 A NZ183136 A NZ 183136A
Authority
NZ
New Zealand
Prior art keywords
prostaclandis
monospiroalkyl
derivatives
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
NZ183136A
Inventor
W Woessner
W Biddlecom
H Arndt
Original Assignee
Miles Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/758,124 external-priority patent/US4098823A/en
Application filed by Miles Lab filed Critical Miles Lab
Publication of NZ183136A publication Critical patent/NZ183136A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/44Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ183136A 1976-02-11 1977-01-20 Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions NZ183136A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65722276A 1976-02-11 1976-02-11
US05/758,124 US4098823A (en) 1976-02-11 1977-01-10 Monospiroalkyl derivatives of prostaglandins

Publications (1)

Publication Number Publication Date
NZ183136A true NZ183136A (en) 1978-11-13

Family

ID=27097362

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183136A NZ183136A (en) 1976-02-11 1977-01-20 Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions

Country Status (5)

Country Link
JP (1) JPS52116444A (en)
DE (1) DE2705590C3 (en)
FR (1) FR2355820A1 (en)
GB (2) GB1568553A (en)
NZ (1) NZ183136A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5468734U (en) * 1977-10-21 1979-05-16
CN104725291B (en) * 2015-02-12 2017-06-16 领思科技(大连)有限公司 XPO1 protein inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL43571A (en) * 1972-11-08 1977-08-31 Pfizer Omega-pentanorprostaglandins and their preparation

Also Published As

Publication number Publication date
DE2705590A1 (en) 1977-08-18
DE2705590B2 (en) 1978-11-09
FR2355820A1 (en) 1978-01-20
GB1568553A (en) 1980-05-29
GB1569252A (en) 1980-06-11
DE2705590C3 (en) 1979-07-05
JPS52116444A (en) 1977-09-29

Similar Documents

Publication Publication Date Title
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ185105A (en) Thiazolidine derivatives and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
PH16022A (en) Acylamino derivatives and pharmaceutical compositions thereof
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
NZ186119A (en) 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
PH13392A (en) Thiourea derivatives and pharmaceutical compositions containing them
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
IL51955A0 (en) Novel thiazole derivatives their preparation and pharmaceutical compositions containing them
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
NZ185267A (en) Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
IL53642A0 (en) New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them
NZ187195A (en) Benzenesulphonyl-urea derivatives and pharmaceutical compositions
NZ184367A (en) 2-vinyl-chromone derivatives and pharmaceutical compositions